Quick Takeaways
- Nathan Caffo has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $5,400.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Nathan Caffo
- Location
- Burlingame, CA
- Summary
- The estimated net worth of Nathan Caffo is at least $5,400 dollars as of 02 Aug 2021. Nathan Caffo is the Chief Business Officer of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $5.4K.
- Signature
- /s/ John Canepa, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Nathan Caffo and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Candel Therapeutics, Inc. ($5,400).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Nathan Caffo
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | Chief Business Officer | $5,400 | 29 Jul 2021 |
Insider Transactions Reported by Nathan Caffo:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.